Drug Profile
JTE 451
Alternative Names: JTE-451; JTE-451ALatest Information Update: 28 Jul 2023
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Class Antiallergics; Antipsoriatics; Small molecules
- Mechanism of Action Immunomodulators; Nuclear receptor subfamily 1 group F member 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Plaque psoriasis
- No development reported Autoimmune disorders; Hypersensitivity
Most Recent Events
- 28 Jul 2023 No recent reports of development identified for phase-I development in Plaque-psoriasis(In volunteers) in Japan (Topical, Ointment)
- 29 Jan 2021 Japan Tobacco completes phase-I clinical trials in Plaque psoriasis (In volunteers) in Japan (Topical) (JapicCTI205348)
- 01 Jun 2020 Phase-I clinical trials in Plaque psoriasis (In volunteers) in Japan (Topical) (JapicCTI205348)